Month: May 2021

TORONTO, May 17, 2021 (GLOBE NEWSWIRE) — VITALHUB CORP. (TSXV: VHI) (the “Company” or “VitalHub”), is pleased to announce today it has completed the acquisition (the “Acquisition”) of the on-premise hospital queue management business segment (“Jayex System”) of Jayex Healthcare Limited (ASX: JHL) (“Jayex”), a leading UK and Australian e-health provider of integrated SaaS healthcare services delivery platforms. Total consideration paid by VitalHub is £1.3M (the “Purchase Price”). Jayex received the Purchase Price as (i) £1.04M in cash and (ii) £0.26M in VitalHub common shares (the “Shares”). The Shares were issued at CAD$2.915 per Share, and resulted in 150,078 Shares being issued. In addition, for 24 months after closing of the Acquisition, Jayex may receive an earn-out based on earned revenues of the Jayex System, capped at a...

Top Players Covered in the US Genetic Testing Market Research Report Are Invitae Corporation (San Francisco, U.S.), Ambry Genetics (Aliso Viejo, U.S.), BioReference Laboratories, Inc. (Elmwood Park, U.S.), Progenity, Inc. (San Diego, U.S.), Quest Diagnostics Incorporated (Secaucus, U.S.), Myriad Genetics, Inc. (Salt Lake City, U.S.), Fulgent Genetics (Temple City, U.S.), Burning Rock Biotech Limited (Guangzhou, China) and other key market players. Pune, India, May 17, 2021 (GLOBE NEWSWIRE) — US Genetic Testing Market Size| 2021 Covid-19 Impact On Automotive Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2026 is latest study published by Fortune Business Insights. The US Genetic Testing Market size is expected to gain momentum by...

VANCOUVER, British Columbia, May 17, 2021 (GLOBE NEWSWIRE) — GT Gold Corp. (TSX-V:GTT; OTCQX:GTGDF) (the “Company” or “GT Gold”) is pleased to announce the successful completion of the previously-announced plan of arrangement with Newmont Corporation i under the Business Corporations Act (British Columbia) (the “Arrangement”). Pursuant to the Arrangement, Newmont has acquired the remaining 85.1% of the outstanding common shares of the Company not already owned by Newmont or its affiliates. Upon completion of the Arrangement, GT Gold became an indirect wholly-owned subsidiary of Newmont. “Newmont is excited to have the Tatogga project in the highly-sought after Golden Triangle district of British Columbia, Canada, become part of our world-class portfolio and part of our future,” said Newmont President and CEO Tom Palmer. “We look...

Acquisition will give Medivolve immediate access to pharmaceutical distribution and CalVax licensing throughout CA; near term COVID-19 vaccination allocations to follow TORONTO, May 17, 2021 (GLOBE NEWSWIRE) — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare technology and services company, today announced it has signed a binding agreement to acquire 100% of all outstanding shares of Marbella, a nonsterile compounded California state licensed and insured pharmacy. This acquisition advances Medivolve’s growth strategy and expands its ability to deliver patient care through immediate access to pharmaceutical distribution throughout the state of California. “The acquisition of Marbella Pharmacy is an important step forward in executing on our strategic growth strategy,” said David Preiner, CEO of Medivolve....

Transaction to create Nasdaq-listed company focused on advancing Aadi Bioscience’s late-stage pipeline for genetically-defined cancers with alterations in mTOR pathway genes Concurrent $155 million PIPE financing is backed by leading life science investors led by Acuta Capital Partners and KVP Capital and including Avoro Capital Advisors; Avoro Ventures; Venrock Healthcare Capital Partners; BVF Partners, L.P.; Vivo Capital; Alta Bioequities, L.P.; Rock Springs Capital; RTW Investments, LP; Acorn Bioventures; and Serrado Capital LLC Combined company cash at closing will fund operations into 2024Rolling NDA submission to the FDA for FYARROTM in advanced malignant perivascular epithelioid sarcoma (PEComa) expected to be completed in mid-2021 FYARROTM preliminary data in patients with solid tumors harboring inactivating alterations in the...

BOSTON & PHILADELPHIA, May 17, 2021 (GLOBE NEWSWIRE) —HouseWorks, one of the nation’s largest independent home care companies, announced today that it has acquired Intervention Associates, a leading care management company that has served Greater Philadelphia for more than 30 years. The acquisition of Intervention Associates adds bench strength to the HouseWorks family of companies’ in-home care services that are offered through Caring Friends Home Care in Greater Philadelphia.  Intervention Associates’ talented and experienced care managers will significantly enhance Caring Friends’ ability to provide specialized services to clients and families —becoming their ‘quarterbacks’ as they navigate every possible challenge of aging at home. Michael Trigilio, CEO of HouseWorks commented: “I am thrilled to welcome the Intervention...